Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer

Inclusion Criteria:

   - The patient has histological diagnosis of cancer of the endometrium of any histology
   or grade.

   - The patient should have received no prior treatment for her endometrial cancer.

   - The patient has clinically uterine confined disease.

   - The patient is a candidate for minimal invasive surgery, with sentinel lymph node
   assessment with IC-GREEN planned as part of standard of care.

   - The patient has an Eastern Cooperative Group (ECOG) performance status of 0-2.

   - If age less than or equal to 55 years, the patient has a negative pregnancy test
   within 72 hours before administration of Lymphoseek, has been surgically sterilized,
   or has been postmenopausal for at least 1 year.

   - The patient has provided written informed consent.

   - The patient is at least 18 years of age at the time of consent

Exclusion Criteria:

   - The patient has clinical or radiological evidence of metastatic disease.

   - The patient has a history of a prior loop electrosurgical excision procedure (LEEP) or
   cone procedure performed on her cervix.

   - The patient has participated in another investigational drug study within 30 days of
   scheduled surgery.

   - The patient has an iodine allergy.

   - The patient is pregnant or lactating.